.webp)
Innovative Research Highlights Targeted Nanotechnology in the Fight Against Cancer, Promising Reduced Side Effects and Enhanced Treatment Efficiency.
Chulalongkorn University recently hosted the international conference "Cutting-edge Nanotechnologies for Good Health and Well-being," where leading scientists, medical professionals, and researchers gathered to explore the future of cancer treatment. A highlight of the event was the presentation of the "OXIGENATED" project, an innovative cancer treatment research funded by the Horizon 2020 Marie Skłodowska-Curie Actions (MSCA). Led by Asst. Prof. Dr. Chanchai Boonla from the Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, the project focuses on using nanoparticles combined with photodynamic therapy to target and destroy cancer cells with minimal side effects.
The OXIGENATED project aims to deliver oxygen directly to cancer cells, enhancing the efficacy of treatment and reducing collateral damage to healthy tissue. Currently in pre-clinical testing, this approach offers new hope in the ongoing battle against cancer.
The conference also featured discussions on two additional MSCA-funded projects: SUPRO-GEN, which explores nano-based cancer therapies, and THERABOT, a study on using bacteria to combat cancer. The event fostered collaboration between global institutions, startups, and researchers.
In tandem with the conference, the SPAIN-THAILAND INNOVATION FORUM focused on advancing nanomedicine, emphasizing the future of personalized health. This international partnership underlines the commitment to developing innovative cancer treatments.
.webp)
